Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Por um escritor misterioso
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
Trending 2017: Precision Medicine
Frontiers MicroRNA as an Important Target for Anticancer Drug Development
Next in Precision Medicine: Small Molecule Biomarkers to Personalize Therapy
The expanding role for small molecules in immuno-oncology
Harnessing the modified proteome for increased diagnostic power - Drug Discovery World (DDW)
Plasma biomarkers for Alzheimer's disease: much needed but tough to find
The expanding role for small molecules in immuno-oncology
Vincent Ling on LinkedIn: In a challenging economy, here is a timely article about non-lab based…
Metabolomics: small molecules that matter more - Molecular Omics (RSC Publishing) DOI:10.1039/D0MO00176G
AI Drug Discovery: Key Trends and Developments in Pharma Industry
Biomarker development in the precision medicine era: lung cancer as a case study
Molecules imagined using advanced artificial intelligence show promising results in pre-clinical experiments
Healthcare, Free Full-Text
Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Frontiers Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
de
por adulto (o preço varia de acordo com o tamanho do grupo)
